629 related articles for article (PubMed ID: 12876559)
21. T-lymphocyte entry into the central nervous system.
Hickey WF; Hsu BL; Kimura H
J Neurosci Res; 1991 Feb; 28(2):254-60. PubMed ID: 2033653
[TBL] [Abstract][Full Text] [Related]
22. Differential immune cell dynamics in the CNS cause CD4+ T cell compartmentalization.
Siffrin V; Brandt AU; Radbruch H; Herz J; Boldakowa N; Leuenberger T; Werr J; Hahner A; Schulze-Topphoff U; Nitsch R; Zipp F
Brain; 2009 May; 132(Pt 5):1247-58. PubMed ID: 19179377
[TBL] [Abstract][Full Text] [Related]
23. Distinct and nonredundant in vivo functions of IFNAR on myeloid cells limit autoimmunity in the central nervous system.
Prinz M; Schmidt H; Mildner A; Knobeloch KP; Hanisch UK; Raasch J; Merkler D; Detje C; Gutcher I; Mages J; Lang R; Martin R; Gold R; Becher B; Brück W; Kalinke U
Immunity; 2008 May; 28(5):675-86. PubMed ID: 18424188
[TBL] [Abstract][Full Text] [Related]
24. CD8+ T cells in inflammatory demyelinating disease.
Weiss HA; Millward JM; Owens T
J Neuroimmunol; 2007 Nov; 191(1-2):79-85. PubMed ID: 17920696
[TBL] [Abstract][Full Text] [Related]
25. Immune cell migration as a means to control immune privilege: lessons from the CNS and tumors.
Mrass P; Weninger W
Immunol Rev; 2006 Oct; 213():195-212. PubMed ID: 16972905
[TBL] [Abstract][Full Text] [Related]
26. Vibsanin B preferentially targets HSP90β, inhibits interstitial leukocyte migration, and ameliorates experimental autoimmune encephalomyelitis.
Ye BX; Deng X; Shao LD; Lu Y; Xiao R; Liu YJ; Jin Y; Xie YY; Zhao Y; Luo LF; Ma S; Gao M; Zhang LR; He J; Zhang WN; Chen Y; Xia CF; Deng M; Liu TX; Zhao QS; Chen SJ; Chen Z
J Immunol; 2015 May; 194(9):4489-97. PubMed ID: 25810397
[TBL] [Abstract][Full Text] [Related]
27. Regulation of immune cell entry into the central nervous system.
Engelhardt B
Results Probl Cell Differ; 2006; 43():259-80. PubMed ID: 17068976
[TBL] [Abstract][Full Text] [Related]
28. The functional avidity of virus-specific CD8+ T cells is down-modulated in Borna disease virus-induced immunopathology of the central nervous system.
Engelhardt KR; Richter K; Baur K; Staeheli P; Hausmann J
Eur J Immunol; 2005 Feb; 35(2):487-97. PubMed ID: 15627979
[TBL] [Abstract][Full Text] [Related]
29. [The immune status of the central nervous system].
de Micco C; Toga M
Rev Neurol (Paris); 1988; 144(12):776-88. PubMed ID: 3070691
[TBL] [Abstract][Full Text] [Related]
30. Unveiling the enigma of the CNS as a B-cell fostering environment.
Uccelli A; Aloisi F; Pistoia V
Trends Immunol; 2005 May; 26(5):254-9. PubMed ID: 15866238
[TBL] [Abstract][Full Text] [Related]
31. Immune cell entry to central nervous system--current understanding and prospective therapeutic targets.
Prendergast CT; Anderton SM
Endocr Metab Immune Disord Drug Targets; 2009 Dec; 9(4):315-27. PubMed ID: 20028334
[TBL] [Abstract][Full Text] [Related]
32. Structural immunology and crystallography help immunologists see the immune system in action: how T and NK cells touch their ligands.
Chen Y; Shi Y; Cheng H; An YQ; Gao GF
IUBMB Life; 2009 Jun; 61(6):579-90. PubMed ID: 19472182
[TBL] [Abstract][Full Text] [Related]
33. CD62L is required for the priming of encephalitogenic T cells but does not play a major role in the effector phase of experimental autoimmune encephalomyelitis.
Li O; Liu JQ; Zhang H; Zheng P; Liu Y; Bai XF
Scand J Immunol; 2006 Aug; 64(2):117-24. PubMed ID: 16867156
[TBL] [Abstract][Full Text] [Related]
34. Anti-TWEAK monoclonal antibodies reduce immune cell infiltration in the central nervous system and severity of experimental autoimmune encephalomyelitis.
Desplat-Jégo S; Creidy R; Varriale S; Allaire N; Luo Y; Bernard D; Hahm K; Burkly L; Boucraut J
Clin Immunol; 2005 Oct; 117(1):15-23. PubMed ID: 16027043
[TBL] [Abstract][Full Text] [Related]
35. Central nervous system and blood lymphocytes in experimental allergic encephalomyelitis.
Lublin FD; Tippett DL; Maurer PH
J Clin Lab Immunol; 1983 Mar; 10(3):139-42. PubMed ID: 6842578
[No Abstract] [Full Text] [Related]
36. Appearance of claudin-5
Krajewski D; Paul D; Ge S; Jellison E; Pachter JS
J Neuroinflammation; 2021 Dec; 18(1):296. PubMed ID: 34933669
[TBL] [Abstract][Full Text] [Related]
37. Immune surveillance of the normal human CNS takes place in dependence of the locoregional blood-brain barrier configuration and is mainly performed by CD3(+)/CD8(+) lymphocytes.
Loeffler C; Dietz K; Schleich A; Schlaszus H; Stoll M; Meyermann R; Mittelbronn M
Neuropathology; 2011 Jun; 31(3):230-8. PubMed ID: 21092063
[TBL] [Abstract][Full Text] [Related]
38. Capture, crawl, cross: the T cell code to breach the blood-brain barriers.
Engelhardt B; Ransohoff RM
Trends Immunol; 2012 Dec; 33(12):579-89. PubMed ID: 22926201
[TBL] [Abstract][Full Text] [Related]
39. Protective autoimmunity functions by intracranial immunosurveillance to support the mind: The missing link between health and disease.
Schwartz M; Shechter R
Mol Psychiatry; 2010 Apr; 15(4):342-54. PubMed ID: 20332793
[TBL] [Abstract][Full Text] [Related]
40. Leukocyte-facilitated entry of intracellular pathogens into the central nervous system.
Drevets DA; Leenen PJ
Microbes Infect; 2000 Nov; 2(13):1609-18. PubMed ID: 11113380
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
